Drug
Asp2390
Asp2390: highest development phase Phase 1, developed by Astellas. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Astellas
Trials
| Drug | Phase | Indication |
|---|---|---|
| ASP2390 NCT04184895 | Phase 1 | Allergic to House Dust Mites |
Latest
No recent events.
Follow Asp2390 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.